FDA-approved manufacturing plant opens in Sydney
05 August, 2009 by Tim DeanFacility for manufacture of highly potent sterile injectables opened by Parnell.
Starpharma announces positive trial results
04 August, 2009 by Tim DeanVivaGel demonstrates anti-HIV and herpes simplex virus properties.
Australian biotech market watch 31/07/09
31 July, 2009 by Tim DeanHeartWare, Universal Biosensors, Fisher & Paykel, CSL
Trial of electrical stimulation treatment for depression
28 July, 2009 by Staff WritersParticipants sought for trial using electrical brain stimulation to treat depression.
New method produces better biological factories
27 July, 2009 by Staff WritersParallel gene manipulation speeds up creation of lycopene-producing bacteria.
Australian biotech market watch 24/07/09
24 July, 2009 by Tim DeanAnsell, CathRX, CSL, Primary Health Care, Sirtex, Living Cell Technologies, Biota, Cochlear
New drug may reduce heart attack damage
23 July, 2009 by Staff WritersOne-off drug delivery could dramatically improve treatment of Australia’s number one killer.
Australian biotech market watch 22/07/09
22 July, 2009 by Tim DeanCochlear, Fisher & Paykel, Ramsay, ResMed, Sigma, Sonic Health Care, Primary Health Care
Life and death of a white blood cell
21 July, 2009 by Staff WritersCell division find prompts overhaul of immune response modelling.
ChemGenex appoints new CCO
20 July, 2009 by Tim DeanNew chief commercial officer and senior vice president appointed ahead of omacetaxine launch in 2010.
Australian biotech market watch 17/07/09
17 July, 2009 by Tim DeanAnsell, Cochlear, OMI, CSL, Ramsay, Sonic Health Care, Cellestis, Sirtex
New study offers hope for dyspeptic horses
16 July, 2009 by Staff WritersBioProspect initiates study of Bioeffective A to treat common gastric problem in horses.
Glowing Phase II results for Clinuvel
15 July, 2009 by Tim DeanClinuvel announces positive results in Phase II Solar Urticaria study.
Victorian innovation funding round kicks off
10 July, 2009 by Staff WritersJoint Victoria-Israel Science and Technology R&D Fund, VISTECH, funding round opens.
Australian biotech market watch 03/07/09
03 July, 2009 by Tim DeanCochlear, Healthscope, Blackmores, Ramsey, CSL, ResMed
